Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 464
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Clinical Trials 93
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 88
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,381 Results (Page 46 of 120)
- Relevance
  Sort by

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
820 Pages
Global

From

€1756EUR$2,000USD£1,532GBP

Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Regional Outlook and Forecast, 2022 - 2028

 Report
November 2022
209 Pages
Global

From

€3160EUR$3,600USD£2,757GBP

Obesity Market (2023 Edition) - Analysis By Drug Type (Appetite Suppressants, Combination Drugs, Malabsorption Drugs, Others), Age Group, By Gender, By Region, By Country: Drivers, Trends and Forecast to 2029

 Report
August 2023
270 Pages
Global

From

€2151EUR$2,450USD£1,877GBP

Saxagliptin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
April 2023
72 Pages
Global

From

€3500EUR$4,271USD£3,161GBP

HPV Associated Disorders Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3942EUR$4,490USD£3,439GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cancer Vaccines Market - Global Forecast 2026-2032

 Report
January 2026
192 Pages
Global

From

€3112EUR$3,545USD£2,715GBP

€3458EUR$3,939USD£3,017GBP

Cervical Cancer Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3942EUR$4,490USD£3,439GBP

Leukemia Therapeutics - Global Strategic Business Report

 Report
February 2026
193 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Myelofibrosis Therapeutics - Global Strategic Business Report

 Report
February 2026
136 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Hematology Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
91 Pages
Global

From

€3500EUR$4,271USD£3,161GBP

Anticoagulation Therapy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
116 Pages
Global

From

€3500EUR$4,271USD£3,161GBP

Multiple Myeloma Therapeutics - Global Strategic Business Report

 Report
February 2026
293 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Hurthle Cell Carcinoma Treatment Market - Global Forecast 2026-2032

 Report
January 2026
196 Pages
Global

From

€3112EUR$3,545USD£2,715GBP

€3458EUR$3,939USD£3,017GBP

Retinal Drugs and Biologics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
93 Pages
Global

From

€3500EUR$4,271USD£3,161GBP

Psoriatic Arthritis Therapeutics Market Report and Forecast 2023-2031

 Report
April 2023
160 Pages
Global

From

€4345EUR$4,949USD£3,791GBP

Peptide Vaccine for Tumor Market - Global Forecast 2025-2030

 Report
August 2025
188 Pages
Global

From

€3112EUR$3,545USD£2,715GBP

€3458EUR$3,939USD£3,017GBP

Advanced Cervical Cancer - Pipeline Insight, 2025

 Drug Pipelines
April 2025
160 Pages
Global

From

€2195EUR$2,500USD£1,915GBP

Pharmaceuticals Global Market Report 2022, By Drug Type, Distribution Channel, Drug Classification

 Report
March 2022
500 Pages
Global

From

€5267EUR$6,000USD£4,596GBP

Novel Oral Anti Coagulant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2023
133 Pages
Global

From

€3500EUR$4,271USD£3,161GBP

Cervical Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€2195EUR$2,500USD£1,915GBP

2,381 Results (Page 46 of 120)
- 1
- 44
- 45
- 46
- 47
- 48

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.